Skip to main content
SpringerLink
Log in
Book cover

Mitochondrial DNA, Mitochondria, Disease and Stem Cells pp 1–23Cite as

Clinical Approach to the Diagnosis of Mitochondrial Disease

  • Chapter
  • First Online:

  • 2004 Accesses

Part of the book series: Stem Cell Biology and Regenerative Medicine ((STEMCELL))

Abstract

Mitochondrial diseases are primary disorders of the mitochondrial respiratory chain. They are caused by known or presumed genetic mutations in mitochondrial or nuclear genes encoding subunits of the respiratory chain or a number of nuclear genes required for: import of respiratory chain subunits into mitochondria; assembly of functional respiratory chain complexes; replication, transcription and translation of mitochondrial DNA. This complexity is reflected in the different inheritance patterns of mitochondrial diseases and considerable variability in the clinical presentations throughout life. This chapter summarises the epidemiology and presentation of mitochondrial diseases, the major clinical features and classification schemes and presents a diagnostic approach to patient with a presumed mitochondrial disease.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Notes

  1. 1.

    Recently, a raised serum level of FGF-21 has been reported to be a very sensitive and specific biomarker for muscle-manifesting mitochondrial disease, the area under the receiver-operating curve being 0.95 [62], but this awaits further evaluation.

References

  1. Calvo S, Jain M, Xie X, Sheth SA, Chang B, Goldberger OA et al (2006) Systematic identification of human mitochondrial disease genes through integrative genomics. Nat Genet 38(5):576–582

    Article  PubMed  CAS  Google Scholar 

  2. Vives-Bauza C, Przedborski S (2011) Mitophagy: the latest problem for Parkinson’s disease. Trends Mol Med 17(3):158–165

    Article  PubMed  CAS  Google Scholar 

  3. Chinnery PF, DiMauro S, Shanske S, Schon EA, Zeviani M, Mariotti C et al (2004) Risk of developing a mitochondrial DNA deletion disorder. Lancet 364(9434):592–596

    Article  PubMed  CAS  Google Scholar 

  4. Mazzarello P (1999) A unifying concept: the history of cell theory. Nat Cell Biol 1(1):E13–E15

    Article  PubMed  CAS  Google Scholar 

  5. Engel WK, Cunningham GG (1963) Rapid examination of muscle tissue. An improved trichrome method for fresh-frozen biopsy sections. Neurology 13:919–923

    Article  PubMed  CAS  Google Scholar 

  6. Seligman AM, Karnovsky MJ, Wasserkrug HL, Hanker JS (1968) Nondroplet ultrastructural demonstration of cytochrome oxidase activity with a polymerizing osmiophilic reagent, diaminobenzidine (DAB). J Cell Biol 38(1):1–14

    Article  PubMed  CAS  Google Scholar 

  7. Luft R, Ikkos D, Palmieri G, Ernster L, Afzelius B (1962) A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study. J Clin Invest 41:1776–1804

    Article  PubMed  CAS  Google Scholar 

  8. DiMauro S, Bonilla E, Lee CP, Schotland DL, Scarpa A, Conn H et al (1976) Luft’s disease. Further biochemical and ultrastructural studies of skeletal muscle in the second case. J Neurol Sci 27(2):217–232

    Article  PubMed  CAS  Google Scholar 

  9. Shy GM, Gonatas NK (1964) Human myopathy with giant abnormal mitochondria. Science 145:493–496

    Article  PubMed  CAS  Google Scholar 

  10. Drachman DA (1968) Ophthalmoplegia plus: the neurodegenerative disorders associated with progressive external ophthalmoplegia. Arch Neurol 18(6):654–674

    Article  PubMed  CAS  Google Scholar 

  11. Kearns TP, Sayre GP (1958) Retinitis pigmentosa, external ophthalmoplegia, and complete heart block: unusual syndrome with histologic study in one of two cases. AMA Arch Ophthalmol 60(2):280–289

    Article  PubMed  CAS  Google Scholar 

  12. Olson W, Engel WK, Walsh GO, Einaugler R (1972) Oculocraniosomatic neuromuscular disease with “ragged-red” fibers. Arch Neurol 26(3):193–211

    Article  PubMed  CAS  Google Scholar 

  13. Shapira Y, Harel S, Russell A (1977) Mitochondrial encephalomyopathies: a group of neuromuscular disorders with defects in oxidative metabolism. Isr J Med Sci 13(2):161–164

    PubMed  CAS  Google Scholar 

  14. Egger J, Lake BD, Wilson J (1981) Mitochondrial cytopathy. A multisystem disorder with ragged red fibres on muscle biopsy. Arch Dis Child 56(10):741–752

    Article  PubMed  CAS  Google Scholar 

  15. Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J et al (1981) Sequence and organization of the human mitochondrial genome. Nature 290(5806):457–465

    Article  PubMed  CAS  Google Scholar 

  16. Egger J, Wilson J (1983) Mitochondrial inheritance in a mitochondrially mediated disease. N Engl J Med 309(3):142–146

    Article  PubMed  CAS  Google Scholar 

  17. Hutchison CA, Newbold JE, Potter SS, Edgell MH (1974) Maternal inheritance of mammalian mitochondrial DNA. Nature 251(5475):536–538

    Article  PubMed  CAS  Google Scholar 

  18. Wallace DC, Singh G, Lott MT, Hodge JA, Schurr TG, Lezza AM et al (1988) Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy. Science 242(4884):1427–1430

    Article  PubMed  CAS  Google Scholar 

  19. Holt IJ, Cooper JM, Morgan-Hughes JA, Harding AE (1988) Deletions of muscle mitochondrial DNA. Lancet 1(8600):1462

    Article  PubMed  CAS  Google Scholar 

  20. Goto Y, Nonaka I, Horai S (1990) A mutation in the tRNA (Leu) (UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348(6302):651–653

    Article  PubMed  CAS  Google Scholar 

  21. Shoffner JM, Lott MT, Lezza AM, Seibel P, Ballinger SW, Wallace DC (1990) Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA (Lys) mutation. Cell 61(6):931–937

    Article  PubMed  CAS  Google Scholar 

  22. Zeviani M, Servidei S, Gellera C, Bertini E, DiMauro S, DiDonato S (1989) An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature 339(6222):309–311

    Article  PubMed  CAS  Google Scholar 

  23. Goethem GV, Dermaut B, Löfgren A, Martin JJ, Broeckhoven CV (2001) Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat Genet 28(3):211–212

    Article  PubMed  Google Scholar 

  24. Kaukonen J, Juselius JK, Tiranti V, Kyttälä A, Zeviani M, Comi GP et al (2000) Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science 289(5480):782–785

    Article  PubMed  CAS  Google Scholar 

  25. Nishino I, Spinazzola A, Papadimitriou A, Hammans S, Steiner I, Hahn CD et al (2000) Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations. Ann Neurol 47(6):792–800

    Article  PubMed  CAS  Google Scholar 

  26. Spelbrink JN, Li FY, Tiranti V, Nikali K, Yuan QP, Tariq M et al (2001) Human mitochondrial DNA deletions associated with mutations in the gene encoding twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet 28(3):223–231

    Article  PubMed  CAS  Google Scholar 

  27. Mandel H, Szargel R, Labay V, Elpeleg O, Saada A, Shalata A et al (2001) The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet 29(3):337–341

    Article  PubMed  CAS  Google Scholar 

  28. Saada A, Shaag A, Mandel H, Nevo Y, Eriksson S, Elpeleg O (2001) Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet 29(3):342–344

    Article  PubMed  CAS  Google Scholar 

  29. Bourgeron T, Rustin P, Chretien D, Birch-Machin M, Bourgeois M, Viegas-Péquignot E et al (1995) Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet 11(2):144–149

    Article  PubMed  CAS  Google Scholar 

  30. Ugalde C, Janssen RJ, van den Heuvel LP, Smeitink JAM, Nijtmans LGJ (2004) Differences in assembly or stability of complex I and other mitochondrial OXPHOS complexes in inherited complex I deficiency. Hum Mol Genet 13(6):659–667

    Article  PubMed  CAS  Google Scholar 

  31. Zhu Z, Yao J, Johns T, Fu K, Bie ID, Macmillan C et al (1998) SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nat Genet 20(4):337–343

    Article  PubMed  CAS  Google Scholar 

  32. Papadopoulou LC, Sue CM, Davidson MM, Tanji K, Nishino I, Sadlock JE et al (1999) Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene. Nat Genet 23(3):333–337

    Article  PubMed  CAS  Google Scholar 

  33. Visapää I, Fellman V, Vesa J, Dasvarma A, Hutton JL, Kumar V et al (2002) GRACILE syndrome, a lethal metabolic disorder with iron overload, is caused by a point mutation in BCS1L. Am J Hum Genet 71(4):863–876

    Article  PubMed  Google Scholar 

  34. Miller C, Saada A, Shaul N, Shabtai N, Ben-Shalom E, Shaag A et al (2004) Defective mitochondrial translation caused by a ribosomal protein (MRPS16) mutation. Ann Neurol 56(5):734–738

    Article  PubMed  CAS  Google Scholar 

  35. Bykhovskaya Y, Casas K, Mengesha E, Inbal A, Fischel-Ghodsian N (2004) Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am J Hum Genet 74(6):1303–1308

    Article  PubMed  CAS  Google Scholar 

  36. Schaefer AM, Taylor RW, Turnbull DM, Chinnery PF (2004) The epidemiology of mitochondrial disorders–past, present and future. Biochim Biophys Acta 1659(2–3):115–120

    PubMed  CAS  Google Scholar 

  37. Darin N, Oldfors A, Moslemi AR, Holme E, Tulinius M (2001) The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA abormalities. Ann Neurol 49(3):377–383

    Article  PubMed  CAS  Google Scholar 

  38. Skladal D, Halliday J, Thorburn DR (2003) Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain 126(Pt 8):1905–1912

    Article  PubMed  Google Scholar 

  39. Verity CM, Winstone AM, Stellitano L, Krishnakumar D, Will R, McFarland R (2010) The clinical presentation of mitochondrial diseases in children with progressive intellectual and neurological deterioration: a national, prospective, population-based study. Dev Med Child Neurol 52(5):434–440

    Article  PubMed  Google Scholar 

  40. Castro-Gago M, Blanco-Barca MO, Campos-González Y, Arenas-Barbero J, Pintos-Martínez E, Eirís-Puñal J (2006) Epidemiology of pediatric mitochondrial respiratory chain disorders in northwest Spain. Pediatr Neurol 34(3):204–211

    Article  PubMed  Google Scholar 

  41. Elliott HR, Samuels DC, Eden JA, Relton CL, Chinnery PF (2008) Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet 83(2):254–260

    Article  PubMed  CAS  Google Scholar 

  42. Clark JM, Marks MP, Adalsteinsson E, Spielman DM, Shuster D, Horoupian D et al (1996) MELAS: clinical and pathologic correlations with MRI, xenon/CT, and MR spectroscopy. Neurology 46(1):223–227

    Article  PubMed  CAS  Google Scholar 

  43. Friedman SD, Shaw DWW, Ishak G, Gropman AL, Saneto RP (2010) The use of neuroimaging in the diagnosis of mitochondrial disease. Dev Disabil Res Rev 16(2):129–135

    Article  PubMed  Google Scholar 

  44. Thyagarajan D, Shanske S, Vazquez-Memije M, Vivo DD, DiMauro S (1995) A novel mitochondrial ATPase 6 point mutation in familial bilateral striatal necrosis. Ann Neurol 38(3):468–472

    Article  PubMed  CAS  Google Scholar 

  45. Yonemura K, Hasegawa Y, Kimura K, Minematsu K, Yamaguchi T (2001) Diffusion-weighted MR imaging in a case of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke like episodes. AJNR Am J Neuroradiol 22(2):269–272

    PubMed  CAS  Google Scholar 

  46. Oppenheim C, Galanaud D, Samson Y, Sahel M, Dormont D, Wechsler B et al (2000) Can diffusion weighted magnetic resonance imaging help differentiate stroke from stroke-like events in MELAS? J Neurol Neurosurg Psychiatry 69(2):248–250

    Article  PubMed  CAS  Google Scholar 

  47. Haas RH, Parikh S, Falk MJ, Saneto RP, Wolf NI, Darin N et al (2007) Mitochondrial disease: a practical approach for primary care physicians. Pediatrics 120(6):1326–1333

    Article  PubMed  Google Scholar 

  48. Walker UA, Collins S, Byrne E (1996) Respiratory chain encephalomyopathies: a diagnostic classification. Eur Neurol 36(5):260–267

    Article  PubMed  CAS  Google Scholar 

  49. Wolf NI, Smeitink JAM (2002) Mitochondrial disorders: a proposal for consensus diagnostic criteria in infants and children. Neurology 59(9):1402–1405

    Article  PubMed  Google Scholar 

  50. Bernier FP, Boneh A, Dennett X, Chow CW, Cleary MA, Thorburn DR (2002) Diagnostic criteria for respiratory chain disorders in adults and children. Neurology 59(9):1406–1411

    Article  PubMed  CAS  Google Scholar 

  51. DiMauro S, Bonilla E, Vivo DCD (1999) Does the patient have a mitochondrial encephalomyopathy? J Child Neurol 14(Suppl 1):S23–S35

    PubMed  Google Scholar 

  52. Schwartz M, Vissing J (2002) Paternal inheritance of mitochondrial DNA. N Engl J Med 347(8):576–580

    Article  PubMed  Google Scholar 

  53. Bandelt HJ, Kong QP, Parson W, Salas A (2005) More evidence for non-maternal inheritance of mitochondrial DNA? J Med Genet 42(12):957–960

    Article  PubMed  CAS  Google Scholar 

  54. Chow SL, Rooney ZJ, Cleary MA, Clayton PT, Leonard JV (2005) The significance of elevated CSF lactate. Arch Dis Child 90(11):1188–1189

    Article  PubMed  CAS  Google Scholar 

  55. Finsterer J, Eichberger H, Jarius C (2000) Lactate-stress testing in 54 patients with mitochondriopathy. Eur Arch Psychiatry Clin Neurosci 250(1):36–39

    Article  PubMed  CAS  Google Scholar 

  56. Shaham O, Slate NG, Goldberger O, Xu Q, Ramanathan A, Souza AL et al (2010) A plasma signature of human mitochondrial disease revealed through metabolic profiling of spent media from cultured muscle cells. Proc Natl Acad Sci USA 107(4):1571–1575

    Article  PubMed  CAS  Google Scholar 

  57. Mitochondrial Medicine Society’s Committee on Diagnosis, Haas RH, Parikh S, Falk MJ, Saneto RP, Wolf NI et al (2008) The in-depth evaluation of suspected mitochondrial disease. Mol Genet Metab 94(1):16–37

    Article  PubMed  CAS  Google Scholar 

  58. Scaglia F, Towbin JA, Craigen WJ, Belmont JW, Smith EO, Neish SR et al (2004) Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease. Pediatrics 114(4):925–931

    Article  PubMed  Google Scholar 

  59. Rollins S, Prayson RA, McMahon JT, Cohen BH (2001) Diagnostic yield muscle biopsy in patients with clinical evidence of mitochondrial cytopathy. Am J Clin Pathol 116(3):326–330

    Article  PubMed  CAS  Google Scholar 

  60. Vasta V, Ng SB, Turner EH, Shendure J, Hahn SH (2009) Next generation sequence analysis for mitochondrial disorders. Genome Med 1(10):100

    Article  PubMed  Google Scholar 

  61. Taylor RW, Taylor GA, Morris CM, Edwardson JM, Turnbull DM (1998) Diagnosis of mitochondrial disease: assessment of mitochondrial DNA heteroplasmy in blood. Biochem Biophys Res Commun 251(3):883–887

    Article  PubMed  CAS  Google Scholar 

  62. Suomalainen A, Elo JM, Pietiläinen KH, Hakonen AH, Sevastianova K, Korpela M, Isohanni P, Marjavaara SK, Tyni T, Kiuru-Enari S,Pihko H, Darin N, Õunap K, Kluijtmans LA, Paetau A, Buzkova J, Bindoff LA, Annunen-Rasila J, Uusimaa J, Rissanen A, Yki-Järvinen H, Hirano M, Tulinius M, Smeitink J, Tyynismaa H (2011) FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study. Lancet Neurol 10(9):806–818

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Monash Medical Centre, Level 5, E Block, 246 Clayton Road, Clayton, VIC 3168, Australia

    Dominic Thyagarajan

Authors
  1. Dominic Thyagarajan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dominic Thyagarajan .

Editor information

Editors and Affiliations

  1. , Center for Reproduction and Development, Monash Institute of Medical Research, Wright Street 27-31, Clayton, 3168, Victoria, Australia

    Justin C. St. John

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Thyagarajan, D. (2013). Clinical Approach to the Diagnosis of Mitochondrial Disease. In: St. John, J. (eds) Mitochondrial DNA, Mitochondria, Disease and Stem Cells. Stem Cell Biology and Regenerative Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-101-1_1

Download citation

Publish with us

Policies and ethics

Search

Navigation